AViTA Corporation (TPEX:4735)
Taiwan · Delayed Price · Currency is TWD 32.70
-0.45 (-1.36%)
Jan 22, 2026, 1:30 PM CST
AViTA Market Cap
AViTA has a market cap or net worth of 1.28 billion as of January 22, 2026. Its market cap has decreased by -7.08% in one year.
Market Cap
1.28B
Enterprise Value
864.39M
Revenue
896.85M
Ranking
n/a
PE Ratio
14.25
Stock Price
32.70
Market Cap Chart
Since April 27, 2010, AViTA's market cap has increased from 776.16M to 1.28B, an increase of 64.46%. That is a compound annual growth rate of 3.21%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 22, 2026 | 1.26B | 1.87% |
| Dec 31, 2025 | 1.24B | -9.68% |
| Dec 31, 2024 | 1.37B | 1.74% |
| Dec 29, 2023 | 1.35B | -6.91% |
| Dec 30, 2022 | 1.45B | -32.68% |
| Dec 30, 2021 | 2.15B | -42.25% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caliway Biopharmaceuticals | 254.20B |
| PharmaEssentia | 213.40B |
| Lotus Pharmaceutical | 84.02B |
| Heron Neutron Medical | 69.56B |
| Bora Pharmaceuticals Co., LTD. | 65.48B |
| Oneness Biotech | 33.97B |
| Center Laboratories | 31.09B |
| Lin BioScience | 30.77B |